Obesity: Why Be Concerned?

被引：122

作者：

Brown, W. Virgil ^{[1
]}

Fujioka, Ken ^{[2
]}

Wilson, Peter W. F. ^{[1
]}

Woodworth, Kristina A. ^{[3
]}

机构：

[1] Emory Univ, Sch Med, Dept Internal Med, Atlanta, GA 30033 USA

[2] Scripps Clin, Ctr Weight Management, San Diego, CA USA

[3] SciMantis Commun Inc, Pen Argyl, PA USA

来源：

AMERICAN JOURNAL OF MEDICINE | 2009年 / 122卷 / 04期

关键词：

Cardiovascular disease; Health care costs; Lipoproteins; Metabolic syndrome; Obesity; Risk factor; TYPE-2; DIABETES-MELLITUS; CORONARY-HEART-DISEASE; METABOLIC SYNDROME; INSULIN-RESISTANCE; UNITED-STATES; LIFE-STYLE; CARDIOVASCULAR MORTALITY; ERECTILE DYSFUNCTION; DENSITY-LIPOPROTEIN; SLEEP-APNEA;

D O I：

10.1016/j.amjmed.2009.01.002

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The obesity epidemic in the United States represents a critical public health issue that has the potential to incur major healthcare costs because of the substantial risks associated with excess body fat. Whereas many recognize the significant risk of cardiovascular disease and diabetes mellitus associated with excess body fat, a myriad of other health problems can accompany overweight and obesity, potentially leading to early morbidity and mortality. Public recognition of obesity as an important health crisis, and not simply a matter of cosmetics or lifestyle choice, is clearly needed. A greater awareness of the health risks associated with excess weight will facilitate more frequent obesity screenings and discussions about healthy weight management that have the potential to result in a greater commitment of healthcare resources to effective obesity prevention and management strategies. (C) 2009 Published by Elsevier Inc. The American Journal of Medicine (2009) 122, S4-S11

引用

页码：S4 / S11

页数：8

共 54 条

[21] Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance [J].

Garvey, WT ;

Kwon, S ;

Zheng, D ;

Shaughnessy, S ;

Wallace, P ;

Hutto, A ;

Pugh, K ;

Jenkins, AJ ;

Klein, RL ;

Liao, YL .

DIABETES, 2003, 52 (02) :453-462

[22] Pharmaceutical cost savings of treating obesity with weight loss medications [J].

Greenway, FL ;

Ryan, DH ;

Bray, GA ;

Rood, JC ;

Tucker, EW ;

Smith, SR .

OBESITY RESEARCH, 1999, 7 (06) :523-531

[23]

American Heart Association, 2005, Cardiol Rev, V13, P322

[24]

Haffner Steven M, 2003, Diabetes Care, V26 Suppl 1, pS83

[25] Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. [J].

Hu, FB ;

Manson, JE ;

Stampfer, MJ ;

Colditz, G ;

Liu, S ;

Solomon, CG ;

Willett, WC .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (11) :790-797

[26] PREVALENCE AND SIGNIFICANCE OF ACANTHOSIS NIGRICANS IN AN ADULT OBESE POPULATION [J].

HUD, JA ;

COHEN, JB ;

WAGNER, JM ;

CRUZ, PD .

ARCHIVES OF DERMATOLOGY, 1992, 128 (07) :941-944

[27] National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study [J].

Hunt, KJ ;

Resendez, RG ;

Williams, K ;

Haffner, SM ;

Stern, MP .

CIRCULATION, 2004, 110 (10) :1251-1257

[28] Cardiovascular morbidity and mortality associated with the metabolic syndrome [J].

Isomaa, B ;

Almgren, P ;

Tuomi, T ;

Forsén, B ;

Lahti, K ;

Nissén, M ;

Taskinen, MR ;

Groop, L .

DIABETES CARE, 2001, 24 (04) :683-689

Kaplan, Steven A. ;

Meehan, Alan G. ;

Shah, Arvind .

JOURNAL OF UROLOGY, 2006, 176 (04) :1524-1527

[30] Increased small low-density lipoprotein particle number - A prominent feature of the metabolic syndrome in the Framingham Heart Study [J].

Kathiresan, S ;

Otvos, JD ;

Sullivan, LM ;

Keyes, MJ ;

Schaefer, EJ ;

Wilson, PWF ;

D'Agostino, RB ;

Vasan, RS ;

Robins, SJ .

CIRCULATION, 2006, 113 (01) :20-29

← 1 2 3 4 5 6 →